These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22343093)

  • 1. Characterization of the 8-hydroxyquinoline scaffold for inhibitors of West Nile virus serine protease.
    Ezgimen M; Lai H; Mueller NH; Lee K; Cuny G; Ostrov DA; Padmanabhan R
    Antiviral Res; 2012 Apr; 94(1):18-24. PubMed ID: 22343093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro.
    Lai H; Sridhar Prasad G; Padmanabhan R
    Antiviral Res; 2013 Jan; 97(1):74-80. PubMed ID: 23127365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen.
    Mueller NH; Pattabiraman N; Ansarah-Sobrinho C; Viswanathan P; Pierson TC; Padmanabhan R
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3385-93. PubMed ID: 18606844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus.
    Johnston PA; Phillips J; Shun TY; Shinde S; Lazo JS; Huryn DM; Myers MC; Ratnikov BI; Smith JW; Su Y; Dahl R; Cosford ND; Shiryaev SA; Strongin AY
    Assay Drug Dev Technol; 2007 Dec; 5(6):737-50. PubMed ID: 18181690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the West Nile virus protease substrate specificity and inhibitors.
    Mueller NH; Yon C; Ganesh VK; Padmanabhan R
    Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
    Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
    Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking.
    Ekonomiuk D; Su XC; Ozawa K; Bodenreider C; Lim SP; Yin Z; Keller TH; Beer D; Patel V; Otting G; Caflisch A; Huang D
    PLoS Negl Trop Dis; 2009; 3(1):e356. PubMed ID: 19159012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors.
    Adamek RN; Maniquis RV; Khakoo S; Bridges MD; Salzameda NT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4848-50. PubMed ID: 23886689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of selective and potent human Fab inhibitors directed to the active-site region of the two-component NS2B-NS3 proteinase of West Nile virus.
    Shiryaev SA; Radichev IA; Ratnikov BI; Aleshin AE; Gawlik K; Stec B; Frisch C; Knappik A; Strongin AY
    Biochem J; 2010 Apr; 427(3):369-76. PubMed ID: 20156198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of West Nile virus protease inhibitors based on the 1,3,4,5-tetrasubstituted 1H-pyrrol-2(5H)-one scaffold.
    Gao Y; Samanta S; Cui T; Lam Y
    ChemMedChem; 2013 Sep; 8(9):1554-60. PubMed ID: 23868614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship and improved hydrolytic stability of pyrazole derivatives that are allosteric inhibitors of West Nile Virus NS2B-NS3 proteinase.
    Sidique S; Shiryaev SA; Ratnikov BI; Herath A; Su Y; Strongin AY; Cosford ND
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5773-7. PubMed ID: 19703770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold.
    Aravapalli S; Lai H; Teramoto T; Alliston KR; Lushington GH; Ferguson EL; Padmanabhan R; Groutas WC
    Bioorg Med Chem; 2012 Jul; 20(13):4140-8. PubMed ID: 22632792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
    J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue protease activity: the structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target.
    Phong WY; Moreland NJ; Lim SP; Wen D; Paradkar PN; Vasudevan SG
    Biosci Rep; 2011 Oct; 31(5):399-409. PubMed ID: 21329491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
    Nitsche C; Steuer C; Klein CD
    Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile virus two-component NS2B-NS3 proteinase.
    Radichev I; Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY
    J Gen Virol; 2008 Mar; 89(Pt 3):636-641. PubMed ID: 18272753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
    Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
    Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. West Nile Virus NS2B/NS3 protease as an antiviral target.
    Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
    Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease.
    Schöne T; Grimm LL; Sakai N; Zhang L; Hilgenfeld R; Peters T
    Antiviral Res; 2017 Oct; 146():174-183. PubMed ID: 28927677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.